Peter Garcia
2019 - PDL BioPharma
In 2019, Peter Garcia earned a total compensation of $2.6M as Former Vice President and Chief Financial Officer at PDL BioPharma, a 22% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,000,000 |
|---|---|
| Salary | $290,975 |
| Other | $1,286,285 |
| Total | $2,577,260 |
Garcia received $1.3M in other compensation, accounting for 50% of the total pay in 2019.
Garcia also received $1M in option awards and $291K in salary.
Rankings
In 2019, Peter Garcia's compensation ranked 4,730th out of 13,971 executives tracked by ExecPay. In other words, Garcia earned more than 66.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,730 out of 13,971 | 66th |
Division Manufacturing | 1,761 out of 5,701 | 69th |
Major group Chemicals And Allied Products | 613 out of 2,200 | 72nd |
Industry group Drugs | 516 out of 1,886 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 112 out of 389 | 71st |
Source: SEC filing on July 7, 2020.
Garcia's colleagues
We found four more compensation records of executives who worked with Peter Garcia at PDL BioPharma in 2019.
News
ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
April 22, 2024
ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
April 24, 2023
PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M
July 7, 2020
PDL BioPharma CEO John McLaughlin's 2018 pay rises 20% to $4.1M
April 30, 2019